UTHR FY 2024 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.9B+23.6% YoY

Gross Profit

$2.6B89.2% margin

Operating Income

$1.4B47.9% margin

Net Income

$1.2B41.5% margin

EPS (Diluted)

$24.64

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.1B

Stock-Based Comp.

$144M

Balance Sheet

Total Assets

$7.4B

Total Liabilities

$920M

Stockholders' Equity

$6.4B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.9B	$2.3B	+23.6%
Gross Profit	$2.6B	$2.1B	+24.0%
Operating Income	$1.4B	$1.2B	+16.2%
Net Income	$1.2B	$985M	+21.4%